UncategorizedEmeritusDX and KDx Diagnostics Inc. Announce a Partnership to Offer the URO17 NON-INVASIVE Urine Test for Bladder CancerNovember 10, 20220
UncategorizedKDx Diagnostics And Lister Hospital Announce The Launch Of A Non-Invasive URO17® Urine Test For Bladder Cancer In The United KingdomDecember 7, 20210
